Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Focus shifts to midcaps
Thu, 7 Oct 01:30 pm

Indian indices recovered their opening losses as buying interest returned in heavy weights during the previous two hours of trade. Stocks from the pharma and consumer durable space are trading firm while stocks from the IT and banking space are trading weak.

Both the BSE-Sensex and the NSE-Nifty are trading marginally above the dotted line. BSE-Midcap is up by 1.0% while BSE-Smallcap index is trading 0.9% above yesterday's closing. The rupee is trading at 44.20 to the US dollar.

Pharma stocks are trading mixed with Biocon and Ranbaxy trading firm while Pfizer and Merck Limited are trading weak. Pfizer released its 3QCY10 results yesterday. The company's topline grew by 12.7% YoY for the quarter. This was due to a strong growth of 14.3% in the company's pharmaceutical business as well as a growth of 118% YoY in clinical development operations. However, the company's animal health business increased by 9.3% YoY, capping the company's topline growth. Operating (EBITDA) margins fell from 24.3% in 3QCY09 to 22.1% during the quarter. This is due to a sharp rise of 55% YoY in employee costs as a result of gratuity provision made during the quarter. Other expenditure also increased sharply by 28% YoY putting further pressure on margins. On the other hand, the company got some relief as raw material costs fell by 7% YoY.

FMCG companies are trading firm led by Dabur and Marico. As per a leading financial daily, laundry detergent makers who have been struggling due to rising raw material prices are facing another challenge. The government plans to impose anti-dumping duty on soda ash. Soda ash forms 30% of the total product formulation costs of low price detergents and 15% for premium detergents. It may be noted that at present soda ash attracts a safeguard duty on imports from China at 16%. Since laundry detergent makers operate on thin margins, a price hike of 10-12% is likely if the anti-dumping duty is imposed. This is likely to affect companies like HUL, P&G, Nirma etc.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Focus shifts to midcaps". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.